Navigation Links
Hard To Treat Diseases (HTDS.PK) Stem Cells and Regenerative Medicine
Date:9/1/2009

PIRAN, Slovenia/BELGRADE, Serbia, Sept. 1 /PRNewswire-FirstCall/ - Hard To Treat Diseases (HTDS.PK) financed the participation of Dr. Ivana Gadjanski in the International Summer School for Stem Cells and Regenerative Medicine held in Piran, Slovenia (21-29. Aug 2009) where a number of eminent speakers presented their work. Among them were Dr. Stephen Minger from King's College, London; Dr. Smadar Cohen from Ben-Gurion University of the Negev, Israel; Dr. Thomas Ekstrom from Karolinska Institute, Stockholm, Sweden; Dr. Zoran Ivanovic from EFS, Bordeaux, France; Dr. Dasa Cziskova from Institute of Neurobiology, Kosice, Slovakia, Dr. Tanja Dominko and Dr. Raymond L. Page from Worcester Polytechnic Institute, USA, Dr. Darja Marolt from Columbia University, USA. Several main topics were discussed: stem cell sources most suitable for clinical application, ethical issues related to stem cell use, obstacles of stem cell therapy (e.g. teratoma formation), future clinical trials (the most interest evokes the FDA-approved world's first human clinical trial of an embryonic stem cell-based therapy for acute spinal cord injury which will be perfomed by Geron using their human embrionic stem cell-derived oligodendrocytes GRNOPC1. The Investigational New Drug Application is currently on clinical hold by the FDA pending the agency's review of new nonclinical animal study data submitted by the company. More information availaible from http://www.geron.com/patients/clinicaltrials/hESC.aspx). Also more technical issues were discussed, e.g. types of biomaterials used for scaffolds, types of bioreactors for growing cells, protocols for cell isolation from various tissues, ways of inducing pluripotency in somatic stem cells (producing iPS), using umbilical cord blood as a source of stem cells. Very promising are adipose-derived s
'/>"/>

SOURCE Hard to Treat Diseases
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. New Assessment Quantifies Risks and Benefits of Warfarin Treatment for Atrial Fibrillation
2. Families of Spinal Muscular Atrophy Receives FDA Orphan Drug Designation For Quinazoline495 For The Treatment of Spinal Muscular Atrophy
3. Takeda Initiates Cardiovascular Outcomes Trial for Alogliptin, An Investigational Treatment for Type 2 Diabetes
4. Octapharma Targeting the Major Risk of Hemophilia Treatment - FVIII Antibodies
5. Lurasidone Demonstrated Efficacy in Treating Patients With Schizophrenia in Pivotal Phase 3 Study
6. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
7. Clinical Study Proves Pollogens TriPollar(TM) Radio Frequency Technology is Effective in the Treatment of Stretch Marks
8. Vectibix(R) Significantly Improved Progression-Free Survival in Second-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer
9. Studies Published in the New England Journal of Medicine Highlight Potential New Option in the Treatment of Bone Loss
10. Cancer Centers of North Carolina Offers HDR Brachytherapy for Treatment of Cancerous Tumors
11. Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... SALT LAKE CITY , July 27, 2015 Dynatronics ... Mark approval for its Solaris therapeutic modality products. This approval allows ... and many other countries around the world. "Receiving ... our international sales efforts," stated Kelvyn H. Cullimore Jr. , ... have expanded our distribution network into China , ...
(Date:7/27/2015)... , July 27, 2015 Bloomage BioTechnology Corporation ... a strategic cooperation with the South Korean BioTech Company ... joint venture Medybloom to develop and promote Type A ... . Medytox, the Botulinum Toxin ... is also the fourth company in the world successfully ...
(Date:7/27/2015)... July 27, 2015 Varian Medical Systems UK Ltd ... Service to equip and service two new national NHS proton ... Varian ProBeam ® proton therapy system. Earlier this year, ... for two three-room NHS centers to be constructed in ... Varian expects to book the equipment portion of the order ...
Breaking Medicine Technology:Dynatronics Awarded CE Mark Approval for Its Solaris Products 2Bloomage (00963.HK) and Medytox Inc. set up a Joint Venture To Jointly Develop Botulinum Toxin Market in China 2Bloomage (00963.HK) and Medytox Inc. set up a Joint Venture To Jointly Develop Botulinum Toxin Market in China 3Varian Signs Contracts to Equip Two National Proton Therapy Centers in England 2Varian Signs Contracts to Equip Two National Proton Therapy Centers in England 3Varian Signs Contracts to Equip Two National Proton Therapy Centers in England 4
... Determine How Chest X-Ray CAD Could ... High-Tech Tool for Early Detection, Increased Patient ... and Riverain Medical,today announced the establishment of the ... chest X-ray CAD (computer-aided detection) can improve,practical early ...
... 26 CuraGen Corporation,(Nasdaq: CRGN ), a ... (Copenhagen Stock Exchange: TOPO) announced,today that updated preliminary ... belinostat for T-cell lymphomas, and new preclinical data,evaluating ... presented,at the 2007 American Society of Hematology (ASH) ...
Cached Medicine Technology:Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection 2Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection 3Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection 4Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection 5Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection 6Cleveland Clinic Leading Clinical Program to Improve Early-Stage Lung Cancer Detection 7CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting 2CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting 3CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting 4CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting 5
(Date:7/27/2015)... TX (PRWEB) , ... July 27, 2015 , ... A ... in actual and punitive damages against Canadian stock promoter Robert Kubbernus based on findings ... by a twelve-person jury and accepted by the court in Cause No. 2010-09675; Jo ...
(Date:7/27/2015)... ... ... Throughout its 20 year history, Doctors on Liens has pioneered ... basis. As the personal injury and medical industries have changed, Doctors on Liens ... pain management physicians, to psychologists and more. And while many of these offices ...
(Date:7/27/2015)... ... , ... According to an article published by the Times Free Press ... stemming from intravenous drug use. Intravenous drug use causes more overdoses and is responsible ... including Hepatitis B and C and HIV. Drug treatment facilities in Tennessee have witnessed ...
(Date:7/27/2015)... ... , ... SupplyLogic, a marketing execution partner based in metro New York and ... the blog, Founder and CEO Kevin Sherlock discusses the value in supply chain visibility ... ‘Why is it the closer you get to the ocean, the more seafood costs?’ ...
(Date:7/27/2015)... ... July 27, 2015 , ... Continuing their ongoing community improvement ... greater San Antonio area, is launching a joint charity effort with the South ... Big Sister Organization of South Texas is committed to serving underprivileged and poverty-stricken ...
Breaking Medicine News(10 mins):Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 2Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 3Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 4Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 5Health News:Fryar Law Firm Announces: Jury Awards $19 Million to Investors in Houston Space Teleport 6Health News:Doctors on Liens Adds Highly Respected Physical Therapy Office in Los Angeles 2Health News:Tennessee Sees an Increase in Hepatitis C Infections from Intravenous Heroin Use 2Health News:Tennessee Sees an Increase in Hepatitis C Infections from Intravenous Heroin Use 3Health News:SupplyLogic Releases First Executive Blog on Supply Chain Management Issues 2Health News:Shacklett Insurance Team Joins Local Chapter of Big Brother Big Sister Organization to Initiate Joint Charity Effort to Benefit Children in San Antonio 2Health News:Shacklett Insurance Team Joins Local Chapter of Big Brother Big Sister Organization to Initiate Joint Charity Effort to Benefit Children in San Antonio 3
... Duke University Medical Center have found that a ... cells could be a pioneering treatment for leukemias, ... cells are the main producers of antibodies, the ... uncontrolled production of these B cells is responsible ...
... in Pakistani Kashmir to provide surgery and medical treatment to ... in just 2 hours//. The unit comprises of a total ... unit was transported to Muzaffarabad, the Kashmir capital, in four ... to be a boon to the victims of the natural ...
... with obsessive-compulsive disorder (OCD) have received increased attention ... about whether OCD is characterized by deficits in ... ,Following from a recent study that ... a virtual computerized stove, researchers from the Department ...
... genetically modified mosquito has been created that wipe out natural ... of the world such as India and South Asia. ... the wild in an attempt to combat malaria that is ... ,A similar attempt was made in India in 1970s ...
... since ages, regarded as a mirror of the inner self. However, ... of a stroke and stroke-related death. // ,The study, ... non-invasive diagnostic tool using the eyes to determine whether people have ... study, people who have tiny lesions on the back of the ...
... chromosome 15 regulates inflammation according to scientists. Inflammation has ... disorders, including cancer, cardiovascular disease, diabetes, obesity, Alzheimer’s besides ... of the study said: “Practically every common disease involves ... Foundation for Biomedical Research (SFBR) in San Antonio., ...
Cached Medicine News:Health News:Lesions in the eyes may forecast a stroke 2
... comfortable pre-fabricated orthosis is designed for ... third humeral diaphyseal fractures. The lightweight ... soft tissue compression for optimal control ... motion of both shoulder and elbow ...
... AC Sport Brace is designed for the ... III acromioclavicular separations. Using a pre-inflated aircell, ... the acromioclavicular joint while supporting the arm ... with each AC Sport Brace for additional ...
The Humeral Stabilizing System is a terrific option for immobilization of stable humeral fractures, stablesupracondular fractures, and biceps/triceps repairs....
... Humerus Fracture Brace indications: , Nonoperative treatment ... Postoperative treatment of open humeral shaft fractures ... , After removal of internal or external ... Defects resulting from tumor growth , ...
Medicine Products: